Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial

The majority of adverse events (AEs) were deemed Grade 1 or 2, suggesting that the vaccine's safety profile is suitable for healthy adolescents. For the primary immunogenicity endpoints, a preliminary examination of the GMTs and the positive transfer rate of neutralizing antibodies in the different experimental groups revealed that, in adolescents aged 6-17, the high-dose group displayed significantly higher levels of neutralizing antibodies compared to the medium- and low-dose groups. Adolescents had few side effects from the new inactivated rotavirus vaccination, and it elicited an immune response.

Authors

Institutions

Publication Details

Journal
Vaccines
Published
2025-03-30
DOI
https://doi.org/10.3390/vaccines13040369
Primary Topic
Viral gastroenteritis research and epidemiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial

Jiamei Gao, Qian Tong, Xiaochen Lin, Jun Ye et al.
Vaccines
Viral gastroenteritis research and epidemiology
article

Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial

Jiamei Gao, Qian Tong, Xiaochen Lin, Jun Ye, Na Yin, Jing Pu, Qingchuan Yu, Dongyang Zhao, Yan Zhou, Xiaoqing Hu, Guangwei Feng, Xiangjing Kuang, Xinling Liu, Yan Liu, Rong Chen, Yong Zhang, Hongjun Li, Yanxia Wang, Zhongyu Hu, Jinyuan Wu, Lili Huang, Jiebing Tan, Shan Yi, Wangyang You
article en

Abstract

The majority of adverse events (AEs) were deemed Grade 1 or 2, suggesting that the vaccine's safety profile is suitable for healthy adolescents. For the primary immunogenicity endpoints, a preliminary examination of the GMTs and the positive transfer rate of neutralizing antibodies in the different experimental groups revealed that, in adolescents aged 6-17, the high-dose group displayed significantly higher levels of neutralizing antibodies compared to the medium- and low-dose groups. Adolescents had few side effects from the new inactivated rotavirus vaccination, and it elicited an immune response.

VaccinesVol. 13(4)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), China Banking Regulatory Commission (CN), National Institutes for Food and Drug Control (CN), Henan Provincial Center for Disease Control and Prevention (CN)
Fundamental Research Funds for the Central Universities
Good health and well-being
Openalex Percentile: Top 91%
Viral gastroenteritis research and epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.